These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28159702)

  • 1. A case of Feingold type 2 syndrome associated with keratoconus refines keratoconus type 7 locus on chromosome 13q.
    Sirchia F; Di Gregorio E; Restagno G; Grosso E; Pappi P; Talarico F; Savin E; Cavalieri S; Giorgio E; Mancini C; Pasini B; Mehta JS; Brusco A
    Eur J Med Genet; 2017 Apr; 60(4):224-227. PubMed ID: 28159702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A de novo 13q31.3 microduplication encompassing the miR-17 ~ 92 cluster results in features mirroring those associated with Feingold syndrome 2.
    Siavrienė E; Preikšaitienė E; Maldžienė Ž; Mikštienė V; Rančelis T; Ambrozaitytė L; Gueneau L; Reymond A; Kučinskas V
    Gene; 2020 Aug; 753():144816. PubMed ID: 32473250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feingold syndrome type 2 in a patient from China.
    Lei J; Han L; Huang Y; Long M; Zhao G; Yan S; Zhang J
    Am J Med Genet A; 2021 Jul; 185(7):2262-2266. PubMed ID: 33818875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo 13q31.1-q32.1 interstitial deletion encompassing the miR-17-92 cluster in a patient with Feingold syndrome-2.
    Tassano E; Di Rocco M; Signa S; Gimelli G
    Am J Med Genet A; 2013 Apr; 161A(4):894-6. PubMed ID: 23495052
    [No Abstract]   [Full Text] [Related]  

  • 5. A fourth case of Feingold syndrome type 2: psychiatric presentation and management.
    Ganjavi H; Siu VM; Speevak M; MacDonald PA
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25391829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2.
    Muriello M; Kim AY; Sondergaard Schatz K; Beck N; Gunay-Aygun M; Hoover-Fong JE
    Am J Med Genet A; 2019 Mar; 179(3):410-416. PubMed ID: 30672094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characterizations of 11 new patients with type 1 Feingold syndrome: Proposal for selecting diagnostic criteria and further genetic testing in patients with severe phenotype.
    Tedesco MG; Lonardo F; Ceccarini C; Cesarano C; Digilio MC; Magliozzi M; Rogaia D; Mencarelli A; Leoni C; Piscopo C; Imperatore V; Falco MT; Fontana P; Nardone AM; Novelli A; Troiani S; Seri M; Prontera P
    Am J Med Genet A; 2021 Apr; 185(4):1204-1210. PubMed ID: 33442900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo 4.4-Mb microdeletion in 2p24.3 → p24.2 in a girl with bilateral hearing impairment, microcephaly, digit abnormalities and Feingold syndrome.
    Chen CP; Lin SP; Chern SR; Wu PS; Chang SD; Ng SH; Liu YP; Su JW; Wang W
    Eur J Med Genet; 2012 Nov; 55(11):666-9. PubMed ID: 22842076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of Feingold syndrome 1 dominate in subjects with 2p deletions including MYCN.
    Burnside RD; Molinari S; Botti C; Brooks SS; Chung WK; Mehta L; Schwartz S; Papenhausen P
    Am J Med Genet A; 2018 Sep; 176(9):1956-1963. PubMed ID: 30088856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GENETIC COUNSELLING IN FEINGOLD SYNDROME AND A NOVEL MUTATION.
    Atik T; Güvenç MS; Onay H; Özkinay F; Çoğulu Ö
    Genet Couns; 2016; 27(3):381-384. PubMed ID: 30204967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.
    Fiori E; Babicola L; Andolina D; Coassin A; Pascucci T; Patella L; Han YC; Ventura A; Ventura R
    Behav Genet; 2015 Sep; 45(5):547-59. PubMed ID: 26026879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metacarpophalangeal pattern profile analysis for a 3-month-old infant with Feingold syndrome 2.
    Isobe A; Maeda N; Fujita H; Banno S; Kageyama T; Hatabu N; Sato R; Suzuki E; Miharu M; Komiyama O; Nakashima M; Matsunaga T; Nishimura G; Yamazawa K
    Am J Med Genet A; 2021 Mar; 185(3):952-954. PubMed ID: 33369046
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models.
    Mirzamohammadi F; Kozlova A; Papaioannou G; Paltrinieri E; Ayturk UM; Kobayashi T
    Nat Commun; 2018 Apr; 9(1):1352. PubMed ID: 29636449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the phenotype of feingold syndrome-2.
    Grote LE; Repnikova EA; Amudhavalli SM
    Am J Med Genet A; 2015 Dec; 167A(12):3219-25. PubMed ID: 26360630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in MYCN gene causing congenital absence of the flexor pollicis longus tendon as an unusual presentation of Feingold syndrome 1.
    Peleg A; Kurolap A; Sagi-Dain L; Larom-Khan G; Adir V; Mory A; Paperna T; Shuldiner AR; Gonzaga-Jauregui C; Adir N; Baris Feldman H; Wollstein R
    Clin Dysmorphol; 2021 Apr; 30(2):71-75. PubMed ID: 32925198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined deletion 18q22.2 and duplication/triplication 18q22.1 causes microcephaly, mental retardation and leukencephalopathy.
    Nguyen-Minh S; Drossel K; Horn D; Rost I; Spors B; Kaindl AM
    Gene; 2013 Jul; 523(1):92-8. PubMed ID: 23566840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Patient Diagnosed as Feingold Syndrome Type 2 with Alport Syndrome and Review of the Current Literature.
    Demir Ş; Söylemez MA; Arman A; Ata P
    Mol Syndromol; 2022 Dec; 13(5):447-453. PubMed ID: 36588757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic findings in patients with clinical suspicion of 22q11.2 deletion syndrome.
    Koczkowska M; Wierzba J; Śmigiel R; Sąsiadek M; Cabała M; Ślężak R; Iliszko M; Kardaś I; Limon J; Lipska-Ziętkiewicz BS
    J Appl Genet; 2017 Feb; 58(1):93-98. PubMed ID: 27629806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms.
    Fannemel M; Barøy T; Holmgren A; Rødningen OK; Haugsand TM; Hansen B; Frengen E; Misceo D
    Eur J Med Genet; 2014 Sep; 57(9):513-9. PubMed ID: 24911659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features associated with a 15.41 Mb deletion of chromosome 13q encompassing the MIR17HG locus.
    S Sharaidin H; Knipe S; Bain N; Goel H
    Clin Dysmorphol; 2013 Apr; 22(2):68-70. PubMed ID: 23448905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.